Tags
Results for: Glioblastoma
-
Video ItemVirginia Tech researcher’s 3D model of brain tumor environment could aid personalized treatment , video
Jennifer Munson and her research team’s model of the glioblastoma tumor microenvironment could help with understanding why the cancer is so resistant to treatment and so often returns after surgery.
Date: Nov 29, 2022 -
Article Item
New cancer biologist targets ‘Achilles heel’ in deadly brain cancers , articleCancer biologist Kathleen Mulvaney joins the faculty of the Fralin Biomedical Research Institute at VTC on Oct. 1. Her lab will be in Washington, D.C., on the Children’s National Research & Innovation Campus as part of a partnership between Virginia Tech and Children’s National.
Date: Sep 27, 2022 -
Article Item
Virginia Tech researcher’s 3D model of brain tumor environment could aid personalized treatment , articleScientists have developed a novel 3D tissue-engineered model of the glioblastoma tumor microenvironment that can be used to learn why the tumors return and what treatments will be most effective at eradicating them – right down to a patient-specific level.
Date: Aug 02, 2022 -
Article Item
Interdisciplinary team wins grant to develop drug for brain cancer , articleThe National Institutes of Health is awarding a $3.8 million grant to John Rossmeisl, the Dr. and Mrs. Dorsey Taylor Mahin Professor of Neurology and Neurosurgery at the Virginia-Maryland College of Veterinary Medicine, and Waldemar Debinski, cancer biology professor at Wake Forest School of Medicine. The team will treat human brain cancer with a drug they have previously used to treat canines.
Date: Mar 18, 2022 -
Video ItemScientists at Fralin Biomedical Research Institute develop new strategy for brain cancer treatment , video
In a new study published in Oncogenesis, Zhi Sheng and Rob Gourdie of the Fralin Biomedical Research Institute at VTC describe how two protein-targeting drugs – when combined with chemotherapy – yield synergistic cytotoxicity to treatment-resistant glioblastoma.
Date: Jan 28, 2022 -
Video ItemMeet Jenny Munson, a cancer scientist at the Fralin Biomedical Research Institute , video
Jenny Munson is a principal investigator at the Fralin Biomedical Research Institute who studies the tumor microenvironment in cancers, including glioblastoma, the deadliest form of brain cancer. Munson's lab is located in the new $90-million biomedical research addition building in Roanoke.
Date: Dec 03, 2021 -
Article Item
Ivy Foundation grant aids Fralin Biomedical Research Institute scientist’s search for treatment for deadly brain cancer , articleJennifer Munson, an associate professor at the Fralin Biomedical Research Institute at VTC, an expert in interstitial fluid flow - the movement of liquid within and around living tissues - will use the $500,000 award to further her study of patient-specific therapies for deadly brain tumors.
Date: Sep 21, 2021 -
Article Item
Scientists from Virginia Tech, City of Hope aim to improve therapy for deadly brain cancer , articleResearchers at the Fralin Biomedical Research Institute at VTC and City of Hope believe the complex way fluid flows through glioblastoma tumors holds the key to improving the success of CAR-T cell therapy in treating the cancer and helping more patients survive.
Date: Apr 28, 2021 -
Video ItemHokies for Good: Conquering Cancer through Research Collaboration , video
Join us as we explore the groundbreaking partnership between the Fralin Biomedical Research Institute at VTC and Children's National Hospital in Washington D.C. Deemed a one-of-a-kind endeavor to transform pediatric research and health care, the Children’s National Research & Innovation Campus in Washington, D.C., has been years in the making and Virginia Tech's unprecedented partnership has been key to bringing this unified vision to reality. Our panel discussion with university and hospital leaders and researchers will highlight the innovative ecosystem where best-in-class research partners are advancing, discovering, and developing breakthroughs into new treatments and technologies to benefit children everywhere.
Date: Apr 13, 2021 -
Video ItemTBMH graduate student awarded two grants to advance brain cancer research , video
<div><div><div><div><div><p>Joelle Martin, a graduate research assistant in the Sontheimer Lab at the Fralin Biomedical Research Institute at VTC, received a Zeta Beta Tau Cancer Research Award and a student fellowship funded by Virginia Tech alumnus and benefactor Ray Gaskins.</p></div></div></div></div></div>
Date: Mar 11, 2021 -
Article Item
Of mice, men – and fish: Researchers find parallels in spread of human brain cancer cells in mammals, zebrafish , articleScientists at the Fralin Biomedical Research Institute at VTC have identified a new zebrafish model that could help advance glioblastoma multiforme research.
Date: Feb 11, 2021 -
Article Item
Virginia Tech scientists developing new strategy to thwart Alzheimer’s , articleSupported by a new, five-year, $2.8 million National Institutes of Health grant awarded to Harald Sontheimer, a glial neurobiologist at the Fralin Biomedical Research Institute at VTC, scientists are probing changes caused by aging in the circulatory system in the normal brain and Alzheimer’s disease brain.
Date: Jul 07, 2020 -
Video ItemUsing Microfluidic Chips to Study Flow in the Brain , video
Collaborators from the University of Virginia visit BEAM researcher Jenny Munson for a little shared lab time. Using a microfluidic chip developed by Rebecca Pompano's lab, the researchers induced interstitial flow in small splices of brain. Eventually, they'll use these devices to study flow in glioblastoma, or brain cancer.
Date: Aug 02, 2018 -
Article Item
Collaborative grant takes on brain cancer cell invasion , articleA relatively unexplored area of cancer research, interstitial fluid flow, or the movement of fluid around and through the three-dimensional space surrounding cells, has been shown to lead to an increase in cancer cell invasion. However, the mechanisms of how and why that happens, particularly in cases of brain cancer, are still unknown.
Date: Feb 01, 2018 -
Article Item
Researchers find way to make resistant brain cancer cells sensitive to treatment , articleScientists from the Virginia Tech Carilion Research Institute and clinicians from Carilion Clinic have discovered how to sensitize drug-resistant human glioblastoma cells to chemotherapy.
Date: Nov 16, 2015 -
Article Item
Going viral: Targeting brain cancer cells with a wound-healing drug , article
At the Virginia Tech Carilion Research Institute, three scientists are planning to create a virus capable of destroying brain cancer. It sounds like the stuff of science fiction, but it isn’t hypothetical – the researchers were recently awarded a grant from the Commonwealth Research Commercialization Fund, part of the Center for Innovative Technology, to engineer a viral therapy.
Date: Jan 05, 2015